News | Remington Davis

Category:

All Categories

How eRegulatory Systems Support Clinical Trials

Mar 19th, 2025 in Glossary

As clinical research evolves, so do the tools and technologies that support it. That includes eRegulatory systems (also known as electronic trial master file or eTMF), which offer cloud-based solutions that enhance document management, ensure regulatory compliance, and improve[...]

Why Clinical Trial Budgeting & Project Management Go Hand-In-Hand

Feb 25th, 2025 in Glossary

Successful clinical trials rely on detailed budgeting and strong project management for financial sustainability, regulatory compliance, and operational efficiency. Sponsors and research sites must account for fixed and variable costs while maintaining flexibility to adapt to[...]

Clinical Trial Performance Metrics: A Strategic Approach to Success

Feb 18th, 2025 in Glossary

A clinical trial’s success hinges on more than recruitment numbers and meeting deadlines—it’s about understanding and optimizing every part of the process. Clinical trial performance metrics offer the insight needed to achieve these goals. By tracking and analyzing key[...]

Choosing the Right Vaccine CRO Services To Accelerate Development

Feb 13th, 2025 in Vaccines

There’s growing demand for vaccine CRO services, with numerous factors at play. The pandemic highlighted the need for rapid vaccine development. Platforms like mRNA, which revolutionized COVID-19 vaccines, are now being tested for other conditions. Initiatives have pushed for[...]

Patient Retention in Clinical Trials: Overcoming Challenges To Drive Success

Feb 4th, 2025 in Glossary

Patient retention is vital to the success of clinical trials, yet it doesn’t always receive the same level of attention as patient enrollment. For sponsors and contract research organizations (CROs) to meet their trial goals and stay on schedule, they need to hold onto the[...]

Best Practices to Meet 21 CFR Part 11 Audit Trail Requirements

Jan 21st, 2025 in Glossary

Compliance with 21 CFR Part 11 requires maintaining secure, computer-generated audit trails that document all modifications to electronic records. These trails supportdata integrity by recording what changes were made, who made them, and when. Proper security measures,[...]

AI in Clinical Trials: Can It Move the Needle Faster?

Jan 7th, 2025 in Trends

Clinical trials have a median cost of $19 million, with the average cost exceeding $41 million per trial. Considering the majority of trials face delays—and these can cost anywhere from hundreds of thousands to millions of dollars per day—there’s no shortage of incentive to[...]

Phases of Vaccine Trials: A Comprehensive Breakdown

Dec 17th, 2024 in Glossary

Vaccine development is a detailed process, broken into clearly defined phases. Each phase addresses specific questions about the safety, efficacy, and scalability of new vaccines, with the ultimate goal of protecting public health. Preclinical Vaccine Research Objectives: [...]

How the Clinical Research Staffing Model Is Evolving

Dec 11th, 2024 in Trends

Traditionally, many professionals fell into clinical research by chance, starting at entry-level positions in the field and gradually progressing through the ranks. Now, we’re seeing a shift to a more intentional approach, where four-year bachelor degrees in clinical research[...]

CTMS vs. eTMF: Why Understanding and Integrating These Systems Matters

Dec 5th, 2024 in Glossary

In clinical trials, efficient operations and detailed documentation drive success. A clinical trial management system (CTMS) and an electronic trial master file (eTMF) are two foundational elements, each with distinct purposes. CTMS focuses on operational oversight, while eTMF[...]

The Impact of IRT Data Integration on Clinical Trials

Dec 3rd, 2024 in Glossary

Interactive response technology (IRT) systems have changed the way clinical trials are managed. By automating key processes like patient randomization, drug supply management, and data collection, IRT streamlines operations and ensures precision. The integration of IRT systems[...]

Clinical Trial Compliance: Maintaining Ethical Standards and Participant Safety

Nov 26th, 2024 in Glossary

Compliance in clinical trials is fundamental to protecting the rights of research participants, preserving data integrity, and advancing medical knowledge. To achieve this, trials must adhere to regulatory requirements as well as trial-specific protocols that outline precise[...]

How Electronic Data Capture Is Shaping the Future of Clinical Research

Nov 13th, 2024 in Glossary

*In clinical research, case report forms (CRFs) and electronic data capture (EDC) systems are often used interchangeably. In the context of this article, CRFs refer to the forms that collect the required clinical data for analysis—the actual data points. The EDC system is the[...]

3 Good Reasons To Diversify Your Clinical Research Site Network

Nov 7th, 2024 in Good Clinical Practice

Over the past five years, the clinical research industry has experienced a surge in merger and acquisition (M&A) activity, driven by the need for scale, technological integration, and diversification of capabilities. Companies like Centricity Research and The IMA Group have[...]

Clinical Trial Project Management: From Recruitment to Regulatory Compliance

Oct 29th, 2024 in Glossary

Effective clinical trial project management supports smooth trial operations by coordinating regulatory compliance, data management, and stakeholder engagement. It's a matter of managing timelines, controlling budgets, and overseeing recruitment strategies to maintain trial[...]

What Causes Delays in Vaccine Trials?

Oct 22nd, 2024 in Vaccines

Vaccine trials are critical to public health, but they are also complex and highly scrutinized. When delays occur, they can have far-reaching consequences, from prolonged time-to-market to increased costs. If your vaccine trial has gone “off the rails” so to speak, it’s crucial[...]

Lyme Disease in Ohio: Causes and Clinical Trials

Oct 11th, 2024 in

Lyme disease is on the rise in Ohio and its border states due to an increase in the population of adult blacklegged ticks, also known as deer ticks. While antibiotics can treat the infection, Lyme disease can still cause both short-term symptoms and potentially lingering[...]

Clinical Trial Data Management Best Practices For Sponsors and CROs

Oct 2nd, 2024 in Glossary

Effectively managing clinical trial data is crucial for maintaining research integrity and compliance. Researchers typically use clinical trial management systems (CTMS) to orchestrate trial operations, and integrate with electronic data capture (EDC) for centralized data[...]

Empowering Acceptance: Supporting Alopecia Awareness Month

Sep 12th, 2024 in Dermatology

September is Alopecia Awareness Month, an opportunity to educate others about alopecia areata, a common autoimmune condition that causes hair loss on the scalp, face, and body. As we deepen our understanding of this condition, we can support and uplift those affected, helping to[...]

What Are The Benefits of A Clinical Trial Management System?

Sep 5th, 2024 in Glossary

A clinical trial management system (CTMS) streamlines clinical trial operations from startup to closeout. It centralizes protocols, subjects, and financials, enhancing efficiency and oversight. Clinical research professionals gain improved visibility into trial progress and[...]

Good Clinical Practice Principles for Sponsors and Investigators

Aug 20th, 2024 in Good Clinical Practice

Good Clinical Practice (GCP) serves as the foundation for maintaining patient safety and data integrity, providing a framework that safeguards patients while facilitating scientific advancements. In this post, we’ll highlight good clinical practice principles and examine recent[...]

10 Milestones in The History Of Vaccines

Aug 10th, 2024 in Vaccines

August is National Immunization Awareness Month, a time to reflect on the importance of vaccinations and ongoing vaccine research. Vaccines are among the most important weapons in the public health arsenal. They have significantly reduced the occurrence of preventable infectious[...]

Trends in Pulmonary & Respiratory Medicine: Insights from Dr. Roy St. John

Jul 17th, 2024 in Pulmonary

With over three decades of experience and a distinguished career, Dr. St. John brings invaluable expertise to our research initiatives. We recently met with him to discuss the latest trends in pulmonary and respiratory medicine, including biologics, triple inhalers, and[...]

The Dynamics of Dermatology Clinical Trials: From New Therapies to Patient Enrollment

Jun 20th, 2024 in News

Dr. Michelle Chambers, a Remington-Davis (RDI) board certified dermatologist, has been involved in dermatological clinical research since the 1990s — she brought her expertise to Remington-Davis in 2019. We recently had the chance to sit down with Dr. Chambers and look at some[...]

Remington-Davis Welcomes Dr. Roy St. John to Its Physician Team

May 30th, 2024 in News

We are excited to announce the new addition to the Remington-Davis family: Dr. Roy St. John. He joins our team of expert board-certified physicians in the central Ohio region that represent over 20 therapeutic areas, including pulmonology. As a board-certified Pulmonary &[...]

Beyond Enrollment: How Site Selection Impacts Patient Retention in Clinical Trials

May 20th, 2024 in News

Patient recruitment is recognized as one of the biggest challenges in clinical research. But getting patients enrolled in clinical trials is just the first step — it then becomes a question of how to keep them engaged in the process. And as research shows, this is easier said[...]

eSource for Clinical Trials: Exploring Challenges & Opportunities

May 6th, 2024 in News

eSource — the electronic capture of clinical trial source data — first gained traction in the late 2000s as technologies like electronic health records (EHRs) and electronic patient diaries became more prevalent. Designed to replace the manual collection and entry of data, the[...]

Applying the Benefits of Decentralized Clinical Trials to Hybrid Trials

Apr 22nd, 2024 in News

The pandemic was a clear catalyst in the rise of decentralized clinical trials (DCTs). But it may come as a surprise to some that this shift from traditional clinical trials was already gaining momentum in the years prior with advancements in technology. Telemedicine platforms,[...]

Advancements in Respiratory Medicine: An Interview With Dr. Edward Cordasco

Apr 15th, 2024 in News

Respiratory medicine is continuously evolving, with new advancements taking shape to support progress and better outcomes every day. We recently discussed some of these advancements with Dr. Edward Cordasco, a Remington-Davis (RDI) board-certified physician with over 36 years of[...]

Diversity in Clinical Trials: The Latest FDA Guidance

Feb 21st, 2024 in News

Diversity has always mattered in clinical trials and health care in general. As the National Institutes of Health (NIH) notes, “people may experience the same disease differently.” With a more diverse pool of clinical trial participants, researchers can better account for these[...]

Why Is It So Hard To Find Healthy Volunteers for Clinical Trials?

Jan 23rd, 2024 in News

Healthy volunteers are a cornerstone of successful clinical trials. Before medications or devices are given to patient groups with a specific condition, interventions on healthy volunteers set a baseline in the early stages of clinical research. These control groups ultimately[...]

Trends in Immunology Clinical Trials: An Interview With Dr. Ian Baird

Jan 17th, 2024 in News

The landscape of immunology clinical trials rarely stands still, from breakthroughs in scientific advancements to changing outlooks on trial dynamics and expectations. Dr. Ian Baird, a Remington-Davis (RDI) board-certified infectious disease physician who has conducted 262[...]

Two OSU nursing students take part in clinical trials that might help battle COVID-19

Jul 31st, 2020 in News

Here’s your chance to catch up on a story featuring two #OSUNursing students who #volunteered for a #clinicaltrial with #RemingtonDavis when they contracted #Covid_19. [...]

Remington-Davis launches dedicated COVID-19 research unit in Ohio

Jul 8th, 2020 in News

By Chris Newmarker | July 8, 2020 Clinical research outfit Remington-Davis recently announced that it has launched a dedicated 3,000 ft2 space in Columbus, Ohio for COVID-19 clinical trials. The space includes six private overnight rooms, patient lounge, dedicated laboratory,[...]